These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25739815)

  • 1. Controlled and Targeted Drug Delivery by a UV-responsive Liposome for Overcoming Chemo-resistance in Non-Hodgkin Lymphoma.
    Li H; Guo K; Wu C; Shu L; Guo S; Hou J; Zhao N; Wei L; Man X; Zhang L
    Chem Biol Drug Des; 2015 Oct; 86(4):783-94. PubMed ID: 25739815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiating antilymphoma efficacy of chemotherapy using a liposome for integration of CD20 targeting, ultra-violet irradiation polymerizing, and controlled drug delivery.
    Wu C; Li H; Zhao H; Zhang W; Chen Y; Yue Z; Lu Q; Wan Y; Tian X; Deng A
    Nanoscale Res Lett; 2014; 9(1):447. PubMed ID: 25221463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel reduction-sensitive micellar nanoparticles assembled from Rituximab-doxorubicin conjugates as smart and intuitive drug delivery systems for the treatment of non-Hodgkin's lymphoma.
    Yin H; Meng T; Shu L; Mao M; Zhou L; Chen H; Song D
    Chem Biol Drug Des; 2017 Nov; 90(5):892-899. PubMed ID: 28440948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes.
    Hatakeyama H; Akita H; Ishida E; Hashimoto K; Kobayashi H; Aoki T; Yasuda J; Obata K; Kikuchi H; Ishida T; Kiwada H; Harashima H
    Int J Pharm; 2007 Sep; 342(1-2):194-200. PubMed ID: 17583453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.
    Gabizon A; Tzemach D; Gorin J; Mak L; Amitay Y; Shmeeda H; Zalipsky S
    Cancer Chemother Pharmacol; 2010 May; 66(1):43-52. PubMed ID: 19779718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human epidermal growth factor receptor-2 antibodies enhance the specificity and anticancer activity of light-sensitive doxorubicin-labeled liposomes.
    Li Q; Tang Q; Zhang P; Wang Z; Zhao T; Zhou J; Li H; Ding Q; Li W; Hu F; Du Y; Yuan H; Chen S; Gao J; Zhan J; You J
    Biomaterials; 2015 Jul; 57():1-11. PubMed ID: 25956192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD20 monoclonal antibody targeted nanoscale drug delivery system for doxorubicin chemotherapy: an in vitro study of cell lysis of CD20-positive Raji cells.
    Jiang S; Wang X; Zhang Z; Sun L; Pu Y; Yao H; Li J; Liu Y; Zhang Y; Zhang W
    Int J Nanomedicine; 2016; 11():5505-5518. PubMed ID: 27843311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasmall nanostructured drug based pH-sensitive liposome for effective treatment of drug-resistant tumor.
    Li Y; Zhai Y; Liu W; Zhang K; Liu J; Shi J; Zhang Z
    J Nanobiotechnology; 2019 Nov; 17(1):117. PubMed ID: 31783863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of Rituximab-resistant B-cell lymphoma with a novel multi-component anti-CD20 mAb nanocluster.
    Li H; Zhang G; Jiang C; Zhang F; Ke C; Zhao H; Sun Y; Zhao M; Chen D; Zhu X; Zhang L; Li B; Dai J; Li W
    Oncotarget; 2015 Sep; 6(27):24192-204. PubMed ID: 26284588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-CD19-targeted liposomal doxorubicin improves the therapeutic efficacy in murine B-cell lymphoma and ameliorates the toxicity of liposomes with varying drug release rates.
    Allen TM; Mumbengegwi DR; Charrois GJ
    Clin Cancer Res; 2005 May; 11(9):3567-73. PubMed ID: 15867261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: a comparison of whole monoclonal antibody, Fab' fragments and single chain Fv.
    Cheng WW; Allen TM
    J Control Release; 2008 Feb; 126(1):50-8. PubMed ID: 18068849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo characterizations of PEGylated liposomal doxorubicin.
    Jiang W; Lionberger R; Yu LX
    Bioanalysis; 2011 Feb; 3(3):333-44. PubMed ID: 21320053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific Conjugation of the Hinge Region for Homogeneous Preparation of Antibody Fragment-Drug Conjugate: A Case Study for Doxorubicin-PEG-anti-CD20 Fab' Synthesis.
    Zhou Z; Zhang J; Zhang Y; Ma G; Su Z
    Bioconjug Chem; 2016 Jan; 27(1):238-46. PubMed ID: 26700095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel two-step mild hyperthermia for advanced liposomal chemotherapy.
    Li L; ten Hagen TL; Haeri A; Soullié T; Scholten C; Seynhaeve AL; Eggermont AM; Koning GA
    J Control Release; 2014 Jan; 174():202-8. PubMed ID: 24269966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous active intracellular delivery of doxorubicin and C6-ceramide shifts the additive/antagonistic drug interaction of non-encapsulated combination.
    Fonseca NA; Gomes-da-Silva LC; Moura V; Simões S; Moreira JN
    J Control Release; 2014 Dec; 196():122-31. PubMed ID: 25305563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular structural transformation regulated dynamic disordering of supramolecular vesicles as pH-responsive drug release systems.
    Liu Y; Gao FP; Zhang D; Fan YS; Chen XG; Wang H
    J Control Release; 2014 Jan; 173():140-7. PubMed ID: 24188958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physicochemical Analysis of DPPC and Photopolymerizable Liposomal Binary Mixture for Spatiotemporal Drug Release.
    Kenaan A; Cheng J; Qi D; Chen D; Cui D; Song J
    Anal Chem; 2018 Aug; 90(15):9487-9494. PubMed ID: 30009597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultraviolet irradiation of diacetylenic liposomes as a strategy to improve size stability and to alter protein binding without cytotoxicity enhancement.
    Temprana CF; Amor MS; Femia AL; Gasparri J; Taira MC; del Valle Alonso S
    J Liposome Res; 2011 Jun; 21(2):141-50. PubMed ID: 20560742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual-targeting nanocarrier system based on thermosensitive liposomes and gold nanorods for cancer thermo-chemotherapy.
    Yu M; Guo F; Tan F; Li N
    J Control Release; 2015 Oct; 215():91-100. PubMed ID: 26256259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoliposome targeting in breast cancer is influenced by the tumor microenvironment.
    Dumont N; Merrigan S; Turpin J; Lavoie C; Papavasiliou V; Geretti E; Espelin CW; Luus L; Kamoun WS; Ghasemi O; Sahagian GG; Muller WJ; Hendriks BS; Wickham TJ; Drummond DC
    Nanomedicine; 2019 Apr; 17():71-81. PubMed ID: 30654182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.